The future of PSCs in toxicology looks promising with advancements in 3D culture systems and organ-on-a-chip technologies. These innovations aim to create more accurate and complex models of human tissues, providing better insights into the toxicological effects of substances. Additionally, the integration of CRISPR-Cas9 technology with PSCs allows for precise genetic modifications, further enhancing their utility in toxicology research.
